All Stories

  1. B cells and atherosclerosis in systemic lupus erythematosus

    Article • Expert Review of Clinical Immunology, January 2019, Taylor & Francis

    Professor Michael Koutsilieris, Dr Clio P Mavragani

  2. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren’s Syndrome Patients

    Article • Journal of Immunology Research, December 2018, Hindawi Publishing Corporation

    Professor Michael Koutsilieris, Eli Gkioka, Dr Clio P Mavragani

  3. Efficacy of a Mediterranean diet supplemented with fatty fish in ameliorating inflammation in paediatric asthma: a randomised controlled trial

    Article • Journal of Human Nutrition and Dietetics, October 2018, Wiley

    Professor Michael Koutsilieris, Maria Papamichael

  4. Risks in Surrogacy Considering the Embryo: From the Preimplantation to the Gestational and Neonatal Period

    Article • BioMed Research International, July 2018, Hindawi Publishing Corporation

    Dr George Anifandis, Professor Michael Koutsilieris

  5. Association between male Infertility and seminal plasma levels of growth hormone and insulin-like growth factor-1

    Article • Andrologia, May 2018, Wiley

    Professor Michael Koutsilieris

  6. Concluding the trilogy: The interaction of 2,2′-dihydroxy-benzophenones and their carbonyl N-analogues with human glutathione transferase M1-1 face to face with the P1-1 and A1-1 isoenzymes involved in MDR

    Article • Chemical Biology & Drug Design, May 2017, Wiley

    Professor Michael Koutsilieris, Trias Thireou

  7. A BAFF Receptor His159Tyr Mutation in Sjögren's Syndrome-Related Lymphoproliferation

    Article • Arthritis & Rheumatology, September 2015, Wiley

    Professor Michael Koutsilieris

  8. FRI0440 Increased Messenger RNA Levels of the Mesenchymal Cadherin-11 in the Peripheral Blood Correlate with Diffuse Skin Involvement in Systemic Sclerosis

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Professor Michael Koutsilieris

  9. A clinicopathological analysis of KISS1 and KISS1R expression in colorectal cancer

    Article • Apmis, May 2015, Wiley

    Professor Michael Koutsilieris

  10. Advanced glycation end-products and insulin signaling in granulosa cells

    Article • Experimental Biology and Medicine, May 2015, SAGE Publications

    Professor Michael Koutsilieris

  11. Vitamin D and breast cancer

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Professor Michael Koutsilieris

  12. Vitamin D and prostate cancer

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Professor Michael Koutsilieris

  13. The effect of melatonin on MCF-7 breast cancer cells in vitro

    Article • May 2015

    Professor Michael Koutsilieris

  14. The effect of melatonin on pC3 prostate cancer cells in vitro

    Article • May 2015

    Professor Michael Koutsilieris

  15. Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations

    Article • Arthritis Research & Therapy, April 2015, Springer Science + Business Media

    Dr Clio P Mavragani, Professor Michael Koutsilieris

  16. Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation

    Article • The Journal of Critical Care Medicine, April 2015, De Gruyter

    Professor Michael Koutsilieris

  17. 44 IGF-1 alternative splicing gene expression as a potential factor in the pathogenesis of Peyronie's disease

    Article • European Urology Supplements, April 2015, Elsevier

    Professor Michael Koutsilieris

  18. The role of the insulin-like growth factor-1 system in breast cancer

    Article • Molecular Cancer, January 2015, Springer Science + Business Media

    Professor Michael Koutsilieris

  19. Cadherin-11 mRNA transcripts are frequently found in rheumatoid arthritis peripheral blood and correlate with established polyarthritis

    Article • Clinical Immunology, November 2014, Elsevier

    Professor Michael Koutsilieris

  20. Research update for articles published in EJCI in 2012

    Article • European Journal of Clinical Investigation, September 2014, Wiley

    Dr Alberto Bouzas-Mosquera, Professor Michael Koutsilieris, Professor Nicolas Roberto Robles

  21. The Multiple Actions of the Insulin-Like Growth Factor-I Signaling in the Myocardium

    Article • September 2014, Springer Science + Business Media

    Professor Michael Koutsilieris

  22. Correlation of platelet activating factor and age-related macular degeneration

    Article • Expert Opinion on Therapeutic Targets, July 2014, Informa Healthcare

    Professor Michael Koutsilieris

  23. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome

    Article • Journal of Autoimmunity, June 2014, Elsevier

    Dr Clio P Mavragani, Professor Michael Koutsilieris

  24. Peripheral targets in obesity treatment: a comprehensive update

    Article • Obesity Reviews, February 2014, Wiley

    Professor Michael Koutsilieris

  25. Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Professor Michael Koutsilieris

  26. Structural and Functional Properties of Deep Abdominal Subcutaneous Adipose Tissue Explain Its Association With Insulin Resistance and Cardiovascular Risk in Men

    Article • Diabetes Care, November 2013, American Diabetes Association

    Professor Michael Koutsilieris

  27. Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer

    Article • Expert Opinion on Investigational Drugs, September 2013, Informa Healthcare

    Professor Michael Koutsilieris

  28. Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications

    Article • Expert Opinion on Therapeutic Targets, September 2013, Informa Healthcare

    Professor Michael Koutsilieris

  29. KISS1 expression in colorectal cancer

    Article • Apmis, September 2013, Wiley

    Professor Michael Koutsilieris

  30. Multiplex PCR-Based Detection of Circulating Tumor Cells in Lung Cancer Patients Using CK19, PTHrP, and LUNX Specific Primers

    Article • Clinical Lung Cancer, September 2013, Elsevier

    Professor Michael Koutsilieris

  31. Anabolic effects of interval exercise training on skeletal muscle of patients with chronic heart failure

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Professor Michael Koutsilieris

  32. Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats

    Article • July 2013, Bioscientifica

    Professor Michael Koutsilieris

  33. THU0012 BAFF Genetic Variants in Lymphomagenesis Associated with Sjogren’s Syndrome

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Clio P Mavragani, Professor Michael Koutsilieris

  34. THU0095 Cadherin-11 Gene is Aberrantly Expressed in the Peripheral Blood of Patients with Rheumatoid Arthritis and Strongly Correlates with Multiple Joint Inflammation

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Professor Michael Koutsilieris

  35. Effects of gender and age on hypothalamic-pituitary-adrenal reactivity after pharmacological challenge with low-dose 1-μg ACTH test: a prospective study in healthy adults

    Article • Clinical Endocrinology, April 2013, Wiley

    Professor Michael Koutsilieris

  36. Advanced glycation end-products inhibit insulin signaling in human granulosa cells

    Article • March 2013

    Professor Michael Koutsilieris

  37. Preoperative serum lactate dehydrogenase levels in colorectal and gastric cancer: a hospital-based case–control study

    Article • Biomarkers in Medicine, February 2013, Future Medicine

    Professor Michael Koutsilieris

  38. Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer

    Article • Frontiers in Endocrinology, January 2013, Frontiers

    Professor Michael Koutsilieris

  39. Wnt signaling in cardiovascular physiology

    Article • Trends in Endocrinology and Metabolism, December 2012, Elsevier

    Professor Michael Koutsilieris

  40. Ocular actions of platelet-activating factor: clinical implications

    Article • Expert Opinion on Therapeutic Targets, August 2012, Informa Healthcare

    Dr Clio P Mavragani, Professor Michael Koutsilieris

  41. Serial changes in adiponectin and resistin in critically ill patients with sepsis: Associations with sepsis phase, severity, and circulating cytokine levels

    Article • Journal of Critical Care, August 2012, Elsevier

    Professor Michael Koutsilieris

  42. Changes in kinematic variables at various muscle lengths of human elbow flexors following eccentric exercise

    Article • Journal of Muscle Research and Cell Motility, July 2012, Springer Science + Business Media

    Professor Michael Koutsilieris

  43. The role of adiponectin in human vascular physiology

    Article • International Journal of Cardiology, March 2012, Elsevier

    Professor Michael Koutsilieris

  44. Biomarkers predicting metabolic syndrome: The role of adiponectin and systemic inflammation

    Article • International Journal of Cardiology, March 2012, Elsevier

    Professor Michael Koutsilieris

  45. Colorectal Cancer Stem Cells

    Article • Stem Cells, February 2012, Wiley

    Professor Michael Koutsilieris

  46. Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer

    Article • European Journal of Clinical Investigation, February 2012, Wiley

    Professor Michael Koutsilieris

  47. Adult-Onset Still’s Disease: From Pathophysiology to Targeted Therapies

    Article • International Journal of Inflammation, January 2012, Hindawi Publishing Corporation

    Dr Clio P Mavragani, Professor Michael Koutsilieris

  48. Cytokines in Muscle Damage

    Article • January 2012, Elsevier

    Professor Michael Koutsilieris

  49. Response to Asymmetrical Dimethylarginine, Oxidative Stress, and Atherosclerosis

    Article • Hypertension, October 2011, Wolters Kluwer Health

    Professor Michael Koutsilieris

  50. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis

    Article • BMC Cancer, August 2011, Springer Science + Business Media

    Professor Michael Koutsilieris

  51. Positive urinary cytology in patients with lung cancer in the absence of obvious urine tract metastases

    Article • Lung Cancer, July 2011, Elsevier

    Professor Michael Koutsilieris

  52. Methods of detection of circulating melanoma cells: A comparative overview

    Article • Cancer Treatment Reviews, June 2011, Elsevier

    Professor Michael Koutsilieris

  53. Role of Asymmetrical Dimethylarginine in Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis

    Article • Hypertension, April 2011, Wolters Kluwer Health

    Dr Clio P Mavragani, Professor Michael Koutsilieris

  54. Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2011, Endocrine Society

    Sarantis Livadas, Professor Michael Koutsilieris

  55. Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS

    Article • Endocrinology, February 2011, Endocrine Society

    Sarantis Livadas, Professor Michael Koutsilieris

  56. Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS

    Article • Endocrine Reviews, February 2011, Endocrine Society

    Sarantis Livadas, Professor Michael Koutsilieris

  57. POSTER VIEWING SESSION - EMBRYOLOGY

    Article • Human Reproduction, January 2011, Oxford University Press (OUP)

    Professor Michael Koutsilieris

  58. Calcium and vitamin D supplementation through fortified dairy products counterbalances seasonal variations of bone metabolism indices: the Postmenopausal Health Study

    Article • European Journal of Nutrition, December 2010, Springer Science + Business Media

    Professor Michael Koutsilieris

  59. Detection of the circulating tumor cells in cancer patients

    Article • Future Oncology, December 2010, Future Medicine

    Professor Michael Koutsilieris

  60. The Impact of Endocrine Disruptors on Endocrine Targets

    Article • Hormone and Metabolic Research, April 2010, Thieme Publishing Group

    Professor Michael Koutsilieris

  61. Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: Evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells

    Article • The Prostate, April 2010, Wiley

    Professor Michael Koutsilieris

  62. Discovery of the mitotic selective chromatid segregation phenomenon and its implications for vertebrate development

    Article • Current Opinion in Cell Biology, February 2010, Elsevier

    Professor Michael Koutsilieris

  63. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer

    Article • Journal of Bone and Mineral Research, December 2009, Wiley

    Professor Michael Koutsilieris

  64. Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter

    Article • Molecular Therapy, December 2009, Elsevier

    Professor Michael Koutsilieris

  65. 9035 Positive urine cytology in patients with lung cancer without obvious urine tract metastases

    Article • European Journal of Cancer Supplements, September 2009, Elsevier

    Professor Michael Koutsilieris

  66. Serum Testosterone: a Potentially Adjunct Screening Test for the Assessment of the Risk for Prostate Cancer among Men with Modestly Elevated PSA Values (≥3.0 and <10.0 ng/ml)

    Article • Journal of Men s Health, September 2009, Mary Ann Liebert Inc

    Professor Michael Koutsilieris

  67. Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology

    Article • Expert Opinion on Investigational Drugs, August 2009, Informa Healthcare

    Professor Michael Koutsilieris

  68. Detection of circulating tumor cells in bladder cancer patients

    Article • Cancer Treatment Reviews, May 2009, Elsevier

    Professor Michael Koutsilieris

  69. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2009, De Gruyter

    Professor Michael Koutsilieris

  70. Systemic cytokine response following exercise-induced muscle damage in humans

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2009, De Gruyter

    Professor Michael Koutsilieris, A. Prof Gregory C Bogdanis

  71. Engineered measles virus as a novel oncolytic therapy against prostate cancer

    Article • The Prostate, January 2009, Wiley

    Professor Michael Koutsilieris

  72. The kisspeptin (KiSS-1)/GPR54 system in cancer biology

    Article • Cancer Treatment Reviews, December 2008, Elsevier

    Professor Michael Koutsilieris

  73. Autophagy: a target for therapeutic interventions in myocardial pathophysiology

    Article • Expert Opinion on Therapeutic Targets, November 2008, Informa Healthcare

    Professor Michael Koutsilieris

  74. cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines

    Article • British Journal of Pharmacology, November 2008, Wiley

    Professor Michael Koutsilieris

  75. Mechanisms of the Action of Zoledronic Acid on Human MG-63 Osteosarcoma Cells

    Article • Hormone and Metabolic Research, June 2008, Thieme Publishing Group

    Professor Michael Koutsilieris

  76. Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications

    Article • Expert Opinion on Therapeutic Targets, June 2008, Informa Healthcare

    Professor Michael Koutsilieris, Dr Angelos G Rigopoulos

  77. Mechanisms of bone metastasis in prostate cancer: clinical implications

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, April 2008, Elsevier

    Professor Michael Koutsilieris

  78. Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS)

    Article • The Journal of Steroid Biochemistry and Molecular Biology, April 2008, Elsevier

    Professor Michael Koutsilieris

  79. Evaluation of a clinical attachment in Primary Health Care as a component of undergraduate medical education

    Article • Medical Teacher, January 2008, Taylor & Francis

    Professor Michael Koutsilieris

  80. Serum levels of the osteoprotegerin, receptor activator of nuclear factor κ-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2008, De Gruyter

    Professor Michael Koutsilieris

  81. Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model

    Article • Experimental Physiology, October 2007, Wiley

    Professor Michael Koutsilieris

  82. The non-genomic crosstalk between PPAR-γ ligands and ERK1/2 in cancer cell lines

    Article • Expert Opinion on Therapeutic Targets, July 2007, Informa Healthcare

    Professor Michael Koutsilieris

  83. Combination of somatostatin analogues and dexamethasone (antisurvival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis

    Article • BJU International, July 2007, Wiley

    Professor Michael Koutsilieris

  84. Luteinising hormone-releasing hormone antagonists in prostate cancer therapy

    Article • Expert Opinion on Emerging Drugs, May 2007, Informa Healthcare

    Professor Michael Koutsilieris

  85. 314 COMBINATION OF SOMATOSTATIN ANALOG, DEXAMETHASONE, AND STANDARD ANDROGEN ABLATION THERAPY IN STAGE D3 PROSTATE CANCER PATIENTS WITH BONE METASTASES

    Article • European Urology Supplements, March 2007, Elsevier

    Professor Michael Koutsilieris

  86. Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostat...

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2007, De Gruyter

    Professor Michael Koutsilieris

  87. Insulin-Like Growth Factor-1 Isoform mRNA Expression in Women with Endometriosis: Eutopic Endometrium Versus Endometriotic Cyst

    Article • Annals of the New York Academy of Sciences, December 2006, Wiley

    Professor Michael Koutsilieris

  88. Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach

    Article • Expert Opinion on Investigational Drugs, June 2006, Informa Healthcare

    Professor Michael Koutsilieris

  89. RANDOMISED CONTROLLED CLINICAL TRIAL OF A COMBINATION OF SOMATOSTATIN ANALOG AND DEXAMETHASONE PLUS ZOLEDRONATE VS. ZOLEDRONATE IN PATIENTS WITH ANDROGEN ABLATION REFRACTORY PROSTATE CANCER

    Article • European Urology Supplements, April 2006, Elsevier

    Professor Michael Koutsilieris

  90. Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2006, De Gruyter

    Professor Michael Koutsilieris

  91. The glutamatergic system outside the CNS and in cancer biology

    Article • Expert Opinion on Investigational Drugs, November 2005, Informa Healthcare

    Professor Michael Koutsilieris

  92. Bone Microenvironment-related Growth Factors, Zoledronic Acid and Dexamethasone Differentially Modulate PTHrP Expression in PC-3 Prostate Cancer Cells

    Article • Hormone and Metabolic Research, October 2005, Thieme Publishing Group

    Professor Michael Koutsilieris

  93. PTH-related protein and Type 1 PTH receptor mRNA expression in ventricular myocardial hypertrophy

    Article • Therapy, May 2005, Future Medicine

    Professor Michael Koutsilieris

  94. PTH-related protein and Type 1 PTH receptor mRNA expression in ventricular myocardial hypertrophy

    Article • Therapy, May 2005, Future Medicine

    Professor Michael Koutsilieris

  95. Transforming growth factor 1 expression in uterine leiomyomas and adjacent myometrium

    Article • Therapy, November 2004, Future Medicine

    Professor Michael Koutsilieris

  96. Transforming growth factor β1 expression in uterine leiomyomas and adjacent myometrium

    Article • Therapy, November 2004, Future Medicine

    Professor Michael Koutsilieris

  97. Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone Metastases

    Article • Clinical Cancer Research, July 2004, American Association for Cancer Research (AACR)

    Professor Michael Koutsilieris

  98. The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development

    Article • Current Cancer Drug Targets, May 2004, Bentham Science Publishers

    Professor Michael Koutsilieris

  99. Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells

    Article • The Prostate, May 2004, Wiley

    Professor Michael Koutsilieris

  100. Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study

    Article • Urology, January 2004, Elsevier

    Professor Michael Koutsilieris

  101. Urokinase-Type Plasminogen Activator and Insulin-Like Growth Factor-Binding Protein 3 mRNA Expression in Endometriotic Lesions and Eutopic Endometrium

    Article • Annals of the New York Academy of Sciences, November 2003, Wiley

    Professor Michael Koutsilieris

  102. Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists

    Article • Expert Opinion on Investigational Drugs, August 2003, Informa Healthcare

    Professor Hippokratis Kiaris, Professor Michael Koutsilieris

  103. Angiopoietins in angiogenesis and beyond

    Article • Expert Opinion on Investigational Drugs, June 2003, Informa Healthcare

    Professor Michael Koutsilieris

  104. Mutation analysis of BrCA1, BrCA2, and p53 versus soluble HLA class I and class II in a case of familial endometriosis

    Article • Fertility and Sterility, February 2003, Elsevier

    Professor Michael Koutsilieris

  105. The use of zoledronic acid in painful osseous metastases due to prostate cancer

    Article • European Urology Supplements, February 2003, Elsevier

    Professor Michael Koutsilieris

  106. Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists

    Article • Expert Opinion on Investigational Drugs, January 2003, Informa Healthcare

    Professor Hippokratis Kiaris, Professor Michael Koutsilieris

  107. Angiopoietins in angiogenesis and beyond

    Article • Expert Opinion on Investigational Drugs, January 2003, Informa Healthcare

    Professor Michael Koutsilieris

  108. Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer

    Article • Expert Opinion on Investigational Drugs, February 2002, Informa Healthcare

    Professor Michael Koutsilieris

  109. A Combination Therapy of Dexamethasone and Somatostatin Analog Reintroduces Objective Clinical Responses to LHRH Analog in Androgen Ablation-Refractory Prostate Cancer Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2001, Endocrine Society

    Professor Michael Koutsilieris

  110. A Combination Therapy of Dexamethasone and Somatostatin Analog Reintroduces Objective Clinical Responses to LHRH Analog in Androgen Ablation-Refractory Prostate Cancer Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2001, Endocrine Society

    Professor Michael Koutsilieris

  111. Molecular biology and cellular physiology of refractoriness to androgen ablation therapy in advanced prostate cancer

    Article • Expert Opinion on Investigational Drugs, June 2001, Informa Healthcare

    Professor Michael Koutsilieris

  112. Immunohistochemical localization of insulin-like growth factor–binding protein-3 in eutopic and ectopic endometrial tissues

    Article • Fertility and Sterility, December 1999, Elsevier

    Professor Michael Koutsilieris

  113. Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone‐refractory prostate cancer: Case report

    Article • The Prostate, March 1999, Wiley

    Professor Michael Koutsilieris

  114. Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: Case report

    Article • The Prostate, March 1999, Wiley

    Professor Michael Koutsilieris

  115. Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis

    Article • Urology, August 1998, Elsevier

    Professor Michael Koutsilieris

  116. Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas

    Article • Oncogene, May 1997, Springer Science + Business Media

    Professor Michael Koutsilieris

  117. Cell-Cell Interactions in Osteoblastic Metastasis Caused by Advanced Prostate Cancer

    Article • January 1996, Springer Science + Business Media

    Professor Michael Koutsilieris

  118. Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts.

    Article • Journal of Clinical Investigation, August 1995, American Society for Clinical Investigation

    Professor Michael Koutsilieris

  119. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG-63 human osteosarcoma cells

    Article • International Journal of Cancer, May 1995, Wiley

    Professor Michael Koutsilieris

  120. Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells

    Article • The Prostate, May 1995, Wiley

    Professor Michael Koutsilieris

  121. Skeletal metastases in advanced prostate cancer: cell biology and therapy

    Article • Critical Reviews in Oncology/Hematology, January 1995, Elsevier

    Professor Michael Koutsilieris

  122. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP

    Article • The Prostate, April 1994, Wiley

    Professor Michael Koutsilieris

  123. The Role of Plasma Membrane in the Pathogenesis of Osteoblastic Metastasis

    Article • January 1994, Springer Science + Business Media

    Professor Michael Koutsilieris

  124. Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation

    Article • The Journal of Steroid Biochemistry and Molecular Biology, December 1993, Elsevier

    Professor Michael Koutsilieris

  125. Combination Therapy with Flutamide and the LHRH Agonist [D-Trp6, des-Gly-NH210]LHRH Ethylamide in Stage C Prostatic Carcinoma

    Article • BJU International, November 1993, Wiley

    Professor Michael Koutsilieris

  126. Heparin-sepharose binding growth factors in peritoneal fluid of women with endometriosis

    Article • International Journal of Gynecology & Obstetrics, September 1993, Wiley

    Professor Michael Koutsilieris

  127. Pathophysiology of uterine leiomyomas

    Article • Biochemistry and Cell Biology, May 1992, Canadian Science Publishing

    Professor Michael Koutsilieris

  128. Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: Characterization of the receptors involved

    Article • The Prostate, January 1991, Wiley

    Professor Michael Koutsilieris

  129. Preferential mitogenic activity for myoblast-like cells can be extracted from uterine leiomyoma tissues

    Article • American Journal of Obstetrics and Gynecology, November 1990, Elsevier

    Professor Michael Koutsilieris

  130. Human uterus-derived growth substances for rat bone cells and fibroblasts

    Article • American Journal of Obstetrics and Gynecology, November 1989, Elsevier

    Professor Michael Koutsilieris

  131. Application of octadecylsilyl-silica in purification studies related to the nontransformed rat ventral prostate androgen receptor

    Article • The Prostate, January 1988, Wiley

    Professor Michael Koutsilieris

  132. Effects of human prostatic mitogens on rat bone cells and fibroblasts

    Article • December 1987, Bioscientifica

    Professor Michael Koutsilieris

  133. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.

    Article • Journal of Clinical Investigation, October 1987, American Society for Clinical Investigation

    Professor Michael Koutsilieris

  134. Complete response of lung metastases caused by prostatic cancer after chronic administration of a gonadotropin-releasing hormone analog, buserelin (HOE 766)

    Article • The Prostate, January 1987, Wiley

    Professor Michael Koutsilieris

  135. Objective response and disease outcome in 59 patients with stage D2 prostatic cancer treated with either buserelin or orchiectomy Disease aggressivity and its association with response and outcome

    Article • Urology, March 1986, Elsevier

    Professor Michael Koutsilieris

  136. Selective osteoblast mitogens can be extracted from prostatic tissue

    Article • The Prostate, January 1986, Wiley

    Professor Michael Koutsilieris

  137. Studies of the Multiple Molecular Forms of Bioactive Parathyroid Hormone and Parathyroid Hormone-Like Substances

    Article • January 1986, Elsevier

    Professor Michael Koutsilieris

  138. LIST OF CONTRIBUTORS AND DISCUSSANTS

    Article • January 1986, Elsevier

    Professor Michael Koutsilieris

  139. Long-term follow-up of patients with advanced prostatic carcinoma treated with either buserelin (HOE 766) or orchiectomy: Classification of variables associated with disease outcome

    Article • The Prostate, January 1985, Wiley

    Professor Michael Koutsilieris

  140. Transphenoidal removal of GH secreting adenomas: method of choice for the treatment of acromegaly

    Article • December 1984

    Professor Michael Koutsilieris

  141. Metastatic prostate cancer: hormone dependency and therapeutic efficacy of GnRH analogues

    Article • December 1984

    Professor Michael Koutsilieris

  142. Comparative study on the effects of orchiectomy or chronic administration of HOE 766 (GnRH-A) in patients with advanced prostatic adenocarcinoma

    Article • Journal of Steroid Biochemistry, June 1984, Elsevier

    Professor Michael Koutsilieris

  143. Suppression of testicular steroidogenesis by the GnRH agonistic analogue buserelin (HOE-766) in patients with prostatic cancer: Studies in relation to dose and route of administration

    Article • Journal of Steroid Biochemistry, July 1983, Elsevier

    Professor Michael Koutsilieris

  144. Gonadotropin-releasing hormone agonistic analogues in the treatment of advanced prostatic carcinoma

    Article • The Prostate, January 1983, Wiley

    Professor Michael Koutsilieris

  145. SUPPRESSION OF TESTICULAR STEROIDOGENESIS BY THE GnRH AGONISTIC ANALOGUE BUSERELIN (HOE-766) IN PATIENTS WITH PROSTATIC CANCER: STUDIES IN RELATION TO DOSE AND ROUTE OF ADMINISTRATION

    Article • January 1983, Elsevier

    Professor Michael Koutsilieris

  146. Pituitary function in 8 patients with familial pituitary dwarfism

    Article • Pediatric Research, November 1978, Springer Science + Business Media

    Professor Michael Koutsilieris

  147. Bone Metastasis Microenvironment Participates in the Development of Androgen Ablation Refractoriness and Chemotherapy Resistance of Prostate Cancer Cells Residing in the Skeleton: Clinical Implications

    Article • Springer Science + Business Media

    Professor Michael Koutsilieris